Publicité
Publicité

Contenu connexe

Publicité

MONKEYPOX.pptx

  1. OPENING PRAYER DEAR HEAVENLY FATHER, WE THANK YOU FOR GATHERING ALL OF US TODAY IN THIS IMPORTANT EVENT MAY YOU BESTOW YOUR GUIDANCE AND BLESSINGS ON THIS EVENT, SO THAT WE CAN ENJOY AND APPRECIATE ITS SIGNIFICANCE IN OUR LIVES BLESS EVERYONE PRESENT HERE TODAY, THAT EACH OF US MAY BE ABLE TO SHARE WHAT HE OR SHE HAVE, FOR YOUR GLORY AND HONOR GRANT GOOD HEALTH AND SAFETY TO OUR LOVED ONES LEFT AT HOME, AND PEACE AND GOOD WILL TO ALL MEN. MAY THE VARIOUS ACTIVITIES RELATED TO THIS EVENT BE A SUCCESS, THROUGH YOUR INTERVENTION WE ASK ALL OF THESE IN YOUR NAME, AMEN.
  2. HUMAN MONKEYPOX By: GERESA G. SALTA-SAMONTE,M.D. Occupational/ Family Medicine Infectious Diseases & Tropical Medicine
  3. Few Questions Before We Start  1. Are monkeys the natural reservoir of monkeypox virus?  2. How can we differentiate monkeypox from chickenpox?  3. What is the duration of quarantine if you have been exposed to someone with monkeypox?
  4. Background:
  5.  1st identified in monkeys in 1958  1st human case reported in 1970  Endemic in areas of Africa  Typically, only see sporadic cases outside of Africa in people who have traveled to certain regions or have been in close contact with those travelers  From the 1970s up until 2003, sporadic cases were identified in central and western Africa  Before 1980, case-fatality rate was 17% and secondary transmission was the cause in 9% of cases  From 1981 to 1986, the case-fatality rate was 10% and secondary transmission was the cause in 28%  From 1996 to 1997, the largest outbreak of human monkeypox occurred, which had a case-fatality rate of 1.5% and secondary transmission was the cause in 78%  The 2003 outbreak, was the first documented cases in the western hemisphere with a case-fatality rate of 0% and secondary transmission was the cause in 0%  Cases of Monkeypox in 2022 from May 6th – 20th [2]:  UK: 20 (Confirmed)  Spain: 23 (Unconfirmed)  Portugal 5 (Confirmed) + 15 (Unconfirmed)  US 1 (Confirmed)
  6. What is Monkeypox?  Monkeypox is a disease caused by the monkeypox virus. It is a viral zoonotic disease, meaning that it can spread from animals to humans. It can also spread between people.  The disease is called monkeypox because it was first identified in colonies of monkeys kept for research in 1958. It was only later detected in humans in 1970.
  7. Mode of transmissions: Primary infection (animal to human) a) contact with infected animals b) contact with infected animal products  Secondary infection (human to human) a) contact with infected people b) mother to fetus
  8. Is Monkeypox a sexually transmitted disease?  Monkeypox can spread from one person to another through close physical contact, including sexual contact. It is currently not known whether monkeypox can be spread through sexual transmission routes (e.g., through semen or vaginal fluids), but direct skin-to-skin contact with lesions during sexual activities can spread the virus.  Monkeypox rashes are sometimes found on genitals and in the mouth, which is likely to contribute to transmission during sexual contact. Mouth-to-skin contact could thus cause transmission where skin or mouth lesions are present.
  9. Signs & symptoms
  10. Disease Progression:  Incubation period (5- 21 days)= the virus enters the body & replicates. No symptoms. Virus is present in the blood at the end of this stage  Febrile stage ( 1-4 days)= fever is present plus other symptoms like headache, chills, sore throat, malaise, fatigue, swollen lymph nodes (lymphadenopathy). Virus is present in the blood & small lesions in the mouth may appear towards the end.  Rash stage2 (4 weeks)  Recovery (days to weeks)
  11. Rash Stage  Rash begins as maculopapular lesions of 2 to 5mm in diameter  Typically, centrifugal pattern (from the torso outwards)  Skin lesions typically progress from macular, papular, to vesicular, to pustular, and crust phases over a 14 to 21-day period  In patients with smallpox vaccination the rash will be milder and only ≈50% will have lymphadenopathy
  12. Rash stage
  13.  Rash stage - virus maybe in the blood in the early stage - virus is present in the skin lesions - antibodies are produced & detectable  Recovery stage - patient recovers - antibodies are present in the blood - scars may remain - no more symptoms
  14. Factors affecting the course of the disease: 1. Asymptomatic infection may occur 2. Risk factors for severe illness: a) children b) immunocompromised c) invasive route 3. Prior smallpox vaccination
  15. Complications:  Bacterial superinfection of skin  Skin scarring  Corneal scarring/vision loss  Pneumonia  Dehydration (secondary to painful oral lesions and insensible fluid loss)  Encephalitis  Death (Very rare)
  16. How can we protect ourselves against monkeypox?  by limiting contact with people who have suspected or confirmed monkeypox.  If you do need to have physical contact with someone who has monkeypox because you are a health worker or live together, encourage the infected person to self-isolate and cover any skin lesion if they can (e.g., by wearing clothing over the rash).  wear a medical mask, especially if they are coughing or have lesions in their mouth. You should wear one also.
  17.  Avoid skin-to-skin contact whenever possible and use disposable gloves if you have any direct contact with lesions.  Wear a mask when handling any clothes or bedding if the person cannot do it themselves.  Regularly clean your hands with soap and water or an alcohol-based hand rub  Wash the person’s clothes, towels and bedsheets and eating utensils with warm water and detergent.
  18. What to do when you think you have monkeypox?  Self-isolate  Avoid close contact  Clean hands regularly  Contact your physicians
  19. Treatment:  There is no proven treatment for monkeypox  For contacts of a case, recommend twice daily fever/symptom monitoring for 21 days + Isolation recommended  Currently, CDC recommending airborne and contact precautions (i.e. negative pressure room, N95, gloves, and eye shield)  Pre-exposure smallpox vaccination has been shown to confer 85% protection against monkeypox  Role of post-exposure smallpox vaccination is less clear  According to the CDC, vaccination within 4 days of exposure may prevent disease onset and vaccination within 14 days may reduce disease severity
Publicité